Screening for prostate cancer is useless

Canadian experts opposed the mass holding
PSA test for prostate cancer detection

RemediumThe Committee for the Prevention of Diseases under the Government of Canada has issued new recommendations indicating that there is no need for regular screening for prostate cancer – Recommendations on screening for prostate cancer with the prostate-specific antigen test.

(The press release of the editorial board of the Canadian Medical Association Journal New prostate cancer screening guideline recommends not using PSA test is published on EurekAlert! – VM.)

According to the members of the working group that developed the document, the risk of negative consequences of mass determination of the level of prostate specific antigen (PSA) exceeds the possible benefit of screening.

Prostate cancer is one of the most common oncological diseases among men, the risk of death from this disease for a man is 4%. It is noted that 70% of men who died at the age of 70-79 years, prostate cancer is detected only after death.

Based on the results of clinical studies, scientists have found that patients younger than 55 years and older than 70 years who have passed tests to determine the level of prostate-specific antigen experience many inconveniences with low test effectiveness. According to research, for every thousand patients there is only one patient whose life will be saved thanks to the PSA test. Among the remaining 999, 720 will be negative. Another 280 will be false positive, of which 178 patients will be biopsied – and all manipulations will confirm the absence of cancer.

In conclusion, the experts wrote that the data obtained to date do not indicate a high efficiency of PSA screening in reducing mortality from prostate cancer, however, there is sufficient evidence that such tests can do more harm than good.

Portal "Eternal youth" http://vechnayamolodost.ru29.10.2014